Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer

We tested the clinical utility of combined profiling of Ion Torrent PGM based next-generation sequencing (NGS) and immunohistochemistry (IHC) for assignment to molecularly targeted therapies. A consecutive cohort of 93 patients with advanced/metastatic GC who underwent palliative chemotherapy betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyo Song, Lee, Hanna, Shin, Su-Jin, Beom, Seung-Hoon, Jung, Minkyu, Bae, Sujin, Lee, Eun Young, Park, Kyu Hyun, Choi, Yoon Young, Son, Taeil, Kim, Hyoung-Il, Cheong, Jae-Ho, Hyung, Woo Jin, Park, Jun Chul, Shin, Sung Kwan, Lee, Sang Kil, Lee, Yong Chan, Koom, Woong Sub, Lim, Joon Seok, Chung, Hyun Cheol, Noh, Sung Hoon, Rha, Sun Young, Kim, Hyunki, Paik, Soonmyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503540/
https://www.ncbi.nlm.nih.gov/pubmed/28418920
http://dx.doi.org/10.18632/oncotarget.16409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503540/
https://www.ncbi.nlm.nih.gov/pubmed/28418920
http://dx.doi.org/10.18632/oncotarget.16409

Ejemplares similares